logo
15:49 Jun 24

Lyka Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
70.43
+3.13 (+4.65%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lyka Labs Ltd. Financials

Lyka Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
70.43
+3.13 (+4.65%)
15:49 Jun 24
Quality
image/svg+xml

30/100
Low Financial Strength

Valuation
image/svg+xml

19/100
Expensive Valuation

Technical

52/100
Technically Neutral

Strength

7

Weakness

10

Opportunity

1

Threats

0

-10.85 %

ROE %

-5.74 %

ROA %

-2.81

EPS

25.89

BVPS

-7.81 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
194.08 93.07 111.19 138.5 128.44
Operating Expenses +
92.93 76.23 95.48 120.56 131.93
Raw Material
53.39 38.77 45.63 56.95 51.27
Increase Decrease in Cost
-0.41 -1.21 -0.78 -1.36 -1.08
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
18.06 18.61 26.77 34.63 41.85
Miscellaneous Expenses
74.79 51.44 50.84 70.1 78.89
Operating Profit
101.15 16.84 15.71 17.94 -3.49
Other Income
2.09 3.4 1.45 2.23 3.5
Depreciation
17.35 14.15 12.8 6.77 8.46
Interest
20.13 11.87 4.89 2.27 3.33
Profit before tax and exceptio..
65.77 -5.78 -0.52 11.12 -11.78
Exceptional Items
-6.52 -7.39 -0.41 0 0
PBT
59.25 -13.17 -0.93 11.12 -11.78
Provision for Taxation
20.8 -0.02 1.69 3.19 -1.34
Net Profit
38.44 -13.15 -2.62 7.93 -10.44
NET Profit after MI
39 -13.21 -2.49 8.01 -10.03
EPS
13.57 -4.63 -0.79 2.22 -2.81
Operating Profit Margin (%)
52.12 18.09 14.13 12.95 -2.72
Net Profit Margin (%)
20.09 -14.19 -2.24 5.78 -7.81

Lyka Labs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 58.20 58.20 58.20 58.20 58.20 58.10
FII 0.30 0.20 0.20 0.20 0.20 0.20
Public 0.70 0.60 0.60 0.60 0.70 0.60
Others 40.80 41.00 41.00 41.00 40.90 41.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: